Ralinepag
ROR-PH-302
Phase 3 small_molecule terminated
Quick answer
Ralinepag for PAH is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- PAH
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated